**7. Beyond guidelines: tailored shortened DAPT durations according to stent platforms**

Current guidelines include DAPT length recommendations irrespective of the DES type, encompassing the evidence of the multiple platforms in various trials. It is worth mentioning, however, some recent trials in which specific platforms have been tested in two main scenarios: one stent tested at short vs. longer DAPT durations; and two different stents compared in a short DAPT duration for patients not deemed amenable for prolonged DAPT duration. While acknowledging the limited value of a single trial, they may still be useful for tailored antiplatelet regimens. **Table 4** summarizes the current knowledge of some specific DES platforms in these two scenarios.
